The UK - a springboard to your global growth
By investing in the UK, US companies can fulfill their international ambitions - and UK Trade & Investment is here to help every step of the way
THE BEST ENVIRONMENT FOR BUSINESS
2010 is a difficult year for economies around the world, but at UK Trade & Investment we have reasons to remain confident that the UK possesses a high level of resilience and is well positioned to emerge above its competitors in the new times ahead.
The UK is a leading recipient for US inward investment into Europe and will remain a key global investment destination due to it being a stable investment location and an open economy.
The UK continues to offer a unique combination of success, confidence, ambition, know-how, innovation, creativity and potential. Recognizing current realities, at UK Trade & Investment we believe that the UK continues to be a solid base and a springboard for global growth. According to the World Investment Report 2009, the UK attracted $982.9 million of stock FDI. Approximately a third of this is from US companies. Unlike most of its competitors, however, the UK isn’t just an investment destination – it is an investment multiplier that can boost the value of a company’s investment.
Companies don’t just do business in the UK because they’re interested in the UK market, they also come here to take advantage of a prosperous economy, an international perspective and to become a global force.
Did you know?
- The UK boasts four of the six largest legal services firms in the world and 200 foreign legal services companies.
- Eight of the world’s top 10 largest management consulting firms (based on fee income) are from the UK.
WORLD-CLASS CREATIVITY AND INNOVATION
The UK is internationally acclaimed for creativity, innovation and invention. Its reputation acts as a magnet to attract the best of global creative talent and technological expertize, while work permit and visa requirements ensure that companies can recruit the highly skilled staff that they need to remain competitive.
Did you know?
- The UK is the most popular location in Europe for investment in pharmaceuticals and biotechnology R&D and for staging clinical trials.
- The UK has been awarded over 70 Nobel Prizes in scientific disciplines and it also has the top four universities in Europe.
- The UK is ranked as the best performer in the G8 leading economies per unit of R&D spend.
- The UK automotive design sector is widely acknowledged as a leader in product development.
GATEWAY TO INTERNATIONAL CONNECTIONS
The UK has formed many clusters of business services and technologies that are truly world class. For companies to grow, they need outstanding support networks and, as well as a large market and quality suppliers, the UK also offers global business leaders the opportunity to interact with the very best of their international peers. In short, it is a global business culture that plugs companies into a vital international network of connections.
Did you know?
- Around 700 of 1,500 firms listed on the main London Stock Exchange market are either incorporated overseas or do the majority of their business overseas.
- The UK has the highest number of leading MBA courses in Europe.
- More than 30% of London’s population is made up of different ethnic groups, creating a diverse workforce with an abundance of employees speaking over 300 languages.
HOW UK TRADE & INVESTMENT CAN HELP
The UK government in the form of UK Trade & Investment is fully committed to assisting US companies to set up or expand in the UK.
UK Trade & Investment is the government organization that helps overseas companies bring their high-quality investment to the UK’s dynamic economy – acknowledged as Europe’s best place from which to succeed in global business. UK Trade & Investment also help UK-based companies succeed in the global economy. UK Trade & Investment offers expertize and contacts through its extensive network of specialists in the UK, and in British embassies and other diplomatic offices around the world. UK Trade & Investment provide companies with the tools they require to be competitive on the world stage.
The comprehensive range of services at UK Trade & Investment includes:
- Tailored client account management
- In-depth information provision
- Support from a new cadre of technology specialists
- Support with exporting from the UK.
For more information on UK Trade & Investment , visit:
Website: www.ukti.gov.uk
UK TRADE & INVESTMENT HAS EIGHT LOCATIONS ACROSS THE US:
| UK TRADE & INVESTMENT HAS EIGHT LOCATIONS ACROSS THE US: |
| Boston |
| British Consulate-General, One Broadway Cambridge MA 02142 Tel: +1 617 245 4500 Fax: +1 617 621 0220 |
| Chicago |
| British Consulate-General, The Wrigley Building 400 N Michigan Avenue, Suite 1300, Chicago IL 60611 Tel: +1 312 970 3800 Fax: +1 312 970 3852 |
| Houston |
| British Consulate-General, Wells Fargo Plaza 1000 Louisiana, Suite 1900, Houston, Texas 77002 Tel: +1 713 659 6270 Fax: +1 713 659 7094 |
| Los Angeles |
| British Consulate-General, 11766 Wilshire Boulevard Suite 1200, Los Angeles, California 90025-6538 Tel: +1 310 481 0031 Fax: +1 310 481 2960 |
| Miami |
| British Consulate-General, 1001 Brickell Bay Drive Suite 2800, Miami, FL 33131 Tel: +1 305 374 3500 Fax: +1 305 374 8196 |
| New York |
| British Consulate-General 845 Third Avenue New York, NY 10022 Tel: +1 212 745 0200 Fax: +1 212 745 3062 |
| San Francisco |
| British Consulate-General, Suite 850 1 Sansome Street, San Francisco, CA 94104 Tel: +1 415 617 1300 Fax: +1 415 434 2018 |
| Washington DC |
| British Embassy 3100 Massachusetts Avenue NW Washington DC 008 Tel: +1 202 588 6500 Fax: +1 202 588 7870 |
| For more information, visit: www.ukti.gov.uk |
Case study:
why the South East was “the natural choice”
for a £5 million microbiology center
A US clinical diagnostic firm, whose products include tools used to fight superbug MRSA, has expanded its presence in the UK by opening a new £5 million microbiology research, development and manufacturing facility in East Grinstead, Sussex, UK.
The new Magellan Biosciences center will manufacture its TREK Diagnostic Systems-branded products which are used to determine what drugs and dosage levels are required to treat bacterial and yeast infections. Pinpointing this helps to address the growing problem of drug resistance.
Magellan Biosciences commissioned the new facility to replace its original site in East Grinstead in response to growing demand. With more products in development and the potential to accommodate up to 100 staff, it will allow for further expansion on the same site.
James Whelan, President of Magellan Clinical Diagnostics, explained: “We outgrew our previous facility thanks to increasing demand for our expanding line of susceptibility products, which provide our customers with the cost-effective, and reliable microbiology results they need to make more-informed treatment decisions. “For the past 30 years, East Grinstead has been a key center of operations. A seasoned, experienced workforce develops and manufactures our critical line of susceptibility plates there, so when it came time to choose a location for our expanded facilities, East Grinstead was the natural choice.”
About Magellan
Founded in 2004, Magellan’s innovative technologies make diagnostic testing easier, more cost-effective, and less labor intensive. The company’s products include rapid point-of-care systems to screen children and adults for lead poisoning; microbiology products for blood culture and susceptibility testing that help in the global effort to prevent MRSA and other drug-resistant infections; as well as automated ELISA processing systems for a wide variety of immunoassays – from infectious disease to autoimmune and food-safety testing. Magellan has approximately 290 employees worldwide. Brands include LeadCare, TREK and Dynex.
For more information, visit:
Website: www.magellanbio.com
back
